Fisher & Paykel Healthcare Corporation Limited (FPLB) Stock Price & Analysis
FPLB Stock Chart & Stats
- Day’s Range
- EUR 23.80 - EUR 23.80
- 52-Week Range
- EUR 16.00 - EUR 25.40
- Previous Close
- EUR 23.60
- Volume
- N/A
- Average Volume (3M)
- 4
- Market Cap
- EUR 14.09B
- Enterprise Value
- EUR 21.78B
- Total Cash (Recent Filing)
- EUR 461.10M
- Total Debt (Recent Filing)
- EUR 146.10M
- Price to Earnings (P/E)
- 59.6
- Beta
- 0.33
- Next Earnings
- Nov 25, 2026 (Est.)
- EPS Estimate
- 0.23
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.52%
Bulls Say, Bears Say
Bulls Say
Recurring Consumables Model
Recurring-use consumables create replenishment demand alongside installed equipment, supporting revenue visibility beyond individual hardware purchases. Hospital patient volumes and ongoing homecare replacement needs can help sustain customer relationships, repeat sales, and cash generation over multiple periods.
Strong Growth And Margin Expansion
Broad-based revenue and profit growth, together with substantial gross and operating margin expansion, indicates improved operating leverage and product execution. If sustained, stronger profitability provides resources for research, capacity expansion, and continued investment in the company’s respiratory-care franchise.
Conservative Balance Sheet And Strong Cash Flow
A net-cash position and very low gearing provide financial flexibility to fund capacity, R&D, and strategic infrastructure without relying heavily on borrowing. Strong operating and free cash flow also support dividends and give the company resilience when demand or currency conditions fluctuate.
Bears Say
Tariffs And Logistics Cost Pressure
Tariffs and freight-related surcharges directly pressure gross margin and may persist through FY27, making earnings more dependent on continuous-improvement savings. If policy or logistics costs worsen, the company could face sustained profitability pressure or need to adjust pricing and sourcing.
Hospital Hardware Growth May Normalize
The exceptional hospital hardware performance included pent-up demand, creating a difficult comparison for the next several quarters. A material slowdown would reduce overall revenue growth and could also limit the contribution from associated consumables and newly installed equipment.
Cash Flow Volatility And Elevated Investment
Although current cash generation is strong, the historical swings in free cash flow show that working capital and investment requirements can materially affect conversion. Higher planned spending on land, buildings, and capacity increases near-term cash outflows and execution demands.
Fisher & Paykel Healthcare Corporation Limited News
FPLB FAQ
What was Fisher & Paykel Healthcare Corporation Limited’s price range in the past 12 months?
What is Fisher & Paykel Healthcare Corporation Limited’s market cap?
When is Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date?
How were Fisher & Paykel Healthcare Corporation Limited’s earnings last quarter?
Is Fisher & Paykel Healthcare Corporation Limited overvalued?
Does Fisher & Paykel Healthcare Corporation Limited pay dividends?
What is Fisher & Paykel Healthcare Corporation Limited’s EPS estimate?
How many shares outstanding does Fisher & Paykel Healthcare Corporation Limited have?
What happened to Fisher & Paykel Healthcare Corporation Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Fisher & Paykel Healthcare Corporation Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Fisher & Paykel Healthcare Corporation Limited
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Lewis G. Gradon
- Employees
- 7,396
- Website
- www.fphcare.com
- Address
- 15 Maurice Paykel Place, Auckland, AU, 2013, NZ
Fisher & Paykel Healthcare Corporation Limited (FPLB) Earnings & Revenues
FPLB Earnings Call
Earnings Call SentimentPositive
The earnings call conveyed a predominantly positive operational and financial performance: strong top-line growth, substantial NPAT expansion, margin improvement, robust cash flow, higher dividends and continued investment in capacity and R&D. The company provided constructive FY'27 guidance but also clearly articulated material near-term headwinds — notably U.S. tariffs, surcharges from the Middle East conflict, FX/hedging losses, and the risk of hardware growth normalizing after an exceptional year. Management stressed that continuous improvement and manufacturing/network flexibility should offset many of these pressures, but several macro and policy risks remain.
View all DE:FPLB earnings summariesFPLB Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 10 | 2 | 10 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 6 | 0 | 6 |
